Abstract
The purpose of this study was to investigate the differences in dietary intake, serum level and urinary excretion of taurine between the elderly with dementia and the normal elderly. Subjects with dementia were 22 (8 men, 14 women) and normal were 26 (2 men, 24 women). The general characteristics, anthropometric data were considered together. The blood and urine samples were obtained from the elderly in the morning fasting state. Taurine concentrations in serum and urinary excretion were determined using high performance liquid chromatography (HPLC). Dietary intake data were collected using questionnaires, and analyzed by Computer Aided Nutritional analysis program (CAN-pro 4.0). Statistical analyses were carried out using SPSS 20.0. There were no significant differences in age and BMI (body mass index) between the elderly with dementia and the normal elderly, however, blood total cholesterol, LDL cholesterol and HDL cholesterol levels of the elderly with dementia were relatively higher than the normal elderly. The elderly men with dementia took more lipid, riboflavin higher than the normal elderly men (P < 0.05). The elderly women with dementia took more nutrients except vitamin D, vitamin B12 and taurine than the normal elderly (P < 0.001). There were slight differences in serum taurine level between the two groups. However, urinary excretion of taurine in the elderly with dementia was significantly higher than the normal elderly (41.2%, P < 0.05).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anzano MA, Naewbanij JO, Lamb AJ (1978) Simplified two-step column-chromatographic determination of taurine in urine. Clin Chem 24:321–325
Bartzokis G, Lu PH, Geschwind DH, Tingus K, Huang D, Mendez M (2007) Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry 62(12):1380–1387
Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 10:377–385
Fekkes D, Voskuilen-Kooyman A, Jankie R, Huijmans J (2000) Precise analysis of primary amino acids in urine by an automated high-performance liquid chromatography method: comparison with ion-exchange chromatography. J Chromatogr B Biomed Sci Appl 744:183–188
Gil GP, Diaz SR, Casado JR (2002) Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease. J Nutr Health Aging 7(5):304–308
Inoue H, Fukunaga K, Tsuruta Y (2003) Determination of taurine in plasma by high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagent. Anal Biochem 319:138–142
Javed H, Khan A, Vaibhav K, Khan MM, Ahmad A, Ahmad ME, Ahmad E, Tabassum R, Islam F, Safhi MM, Islam F (2013) Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer’s type (SDAT) caused by intracerebroventricular streptozotocin in rats. Neurol Sci 34:2181–2192
Joseph J, Cole G, Head E, Ingram D (2009) Nutrition, brain aging, and neurodegeneration. J Neurosci 29:12795–12801
Kataoka H, Matsuba K, Makita M (1984) Determination of taurine in whole blood and plasma by gas liquid chromatography. Yakugaku Zasshi 104:1054–1058
Kelly MT, Fabre H, Perrett D (2000) Determination of taurine in plasma by capillary zone electrophoresis following derivatisation with fluorescamine. Electrophoresis 21:699–705
Kim HY, Kim HV, Yoon JH, Kang BR, Cho SM, Lee S, Kim JY, Kim JW, Cho Y, Woo J, Kim YS (2014) Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer’s disease. Sci Rep 2014:7467
Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 12(2):138–145
McMahon GP, O’Kennedy R, Kelly MT (1996) High-performance liquid chromatographic determination of taurine in human plasma using pre-column extraction and derivatization. J Pharm Biomed Anal 14:1287–1294
Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R (1999) Low density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282:254–260
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60(2):194–200
Mou S, Ding X, Liu Y (2002) Separation methods for taurine analysis in biological samples. J Chromatogr B 781:251–267
Panza F, D’Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51(2):275–292
Park T, Kang HW, Park J, Cho S (2001) Dietary intakes, plasma levels and urinary excretions of taurine in adolescents and adults residing in the Seoul area. Kor J Nutr 34:440–448
Prince M, Guerchet M, Prina M (2013) The global impact of dementia 2013–2050. Alzheimer’s Disease International, London
Qu F, Qi ZH, Liu KN, Mou SF (1999) Ion chromatographic determination of taurine in medicine, nutrient capsule and human urine with electrochemical detection. J Chromatogr B Biomed Sci Appl 730:161–166
Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-Thomas T, Wang R (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7(4):321–331
Trautwein EA, Hayes KC (1991) Evaluating taurine status: determination of plasma and whole blood taurine concentration. J Nutr Biochem 2:571–576
Tyson JE, Lasky R, Flood D, Mize C, Picone T, Paule CL (1989) Randomized trial of taurine supplementation for infants\g=le\1300-Gram birth weight: effect on auditory brainstem-evoked responses. Pediatrics 83:406–415
Wakutani Y, Kowa H, Kusumi M, Yamagata K, Wada-Isoe K, Adachi Y, Takeshima T, Urakami K, Nakashima K (2002) Genetic analysis of vascular factors in Alzheimer’s disease. Ann N Y Acad Sci 977:232–238
Wortmann M (2012) Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther 4:40
Zarrouk A, Riedinger JM, Ahmed SH, Hammami S, Chaabane W, Debbabi M, Sofiene BA, Olivier R, Mahbouba F, Gérard L, Mohamed H (2015) Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26: 0) as a blood lipid biomarker of dementia. J Alzheimers Dis 44:1349–1359
Zielinska M, Sawosz E, Grodzik M, Balcerak M, Wierzbicki M, Skomial J, Sawosz F, Chwalibog A (2012) Effect of taurine and gold nanoparticles on the morphological and molecular characteristics of muscle development during chicken embryogenesis. Arch Anim Nutr 66:1–13
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this paper
Cite this paper
Gao, R., Bae, M.A., Chang, K.J., Kim, S.H. (2017). Comparison of Urinary Excretion of Taurine Between Elderly with Dementia and Normal Elderly. In: Lee, DH., Schaffer, S.W., Park, E., Kim, H.W. (eds) Taurine 10. Advances in Experimental Medicine and Biology, vol 975. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1079-2_5
Download citation
DOI: https://doi.org/10.1007/978-94-024-1079-2_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1077-8
Online ISBN: 978-94-024-1079-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)